Education＆ScienceWebinars

APSR Sponsored Webinar (supported by Boehringer Ingelheim)

New data and fresh perspectives in ILD: FIBRONEER trials
#2025 #Boehringer-Ingelheim #Interstitial-Lung-Disease

Share:

X facebook Linkedin

Friday 13 June 2025

  • 17:00-18:00 Singapore, Hong Kong Time (UTC+8)
  • 18:00-19:00 Tokyo time (UTC+9)
  • 19:00-20:00 Sydney time (UTC+10)

Supported by Boehringer Ingelheim

OUTLINE

This webinar provides a space for respiratory health professionals from around the globe to share their experiences. Participants have the chance to ask questions, discuss, and hear perspectives from the speaker.

TOPICS

  • “FIBRONEER Trials: Efficacy and safety of nerandomilast in IPF/ILD Patients” – Prof Daniel Chambers
  • “A Clinician’s Perspective: Redefining ILD Management with Nerandomilast” – Dr Felicia Teo

FORMAT

  1. Opening Remarks
  2. Presentation-1
  3. Presentation-2
  4. Q&A
  5. Closing Remarks

CHAIRPERSONS & SPEAKERS

Prof Daniel Chambers

SPEAKER

Professor of Medicine,
The University of Queensland

Australia

Dr Felicia Teo

SPEAKER

Senior consultant physician
Respiratory & Intensive Care Medicine
The Lung Clinic

Singapore

Dr Jin Woo Song, FAPSR

CHAIRPERSON

Deputy Head of Interstitial Lung Disease Assembly
APSR

Republic of Korea

All webinars